🏛️ Verified NIH Record • Updated 2025-12-01
Fear of Recurrence and Stopping Immunotherapy (NCT04761328)
Distress Associated With Stopping Immunotherapy of Cancer Patients
🟢 Recruiting Observational / Diagnostic 🧠 Behavioral & Psychological Program Sponsor: University of Pittsburgh
🩺 Plain-English Summary (8th-Grade Level)
The study includes participants experiencing distress with regard to stopping immunotherapy and will utilize cognitive-behavioral therapy to reduce fear of recurrence, depression, and anxiety and improve quality of life.
Who can join: Review the eligibility criteria below.
Location: UPMC Hillman Cancer Centers — Pittsburgh, Pennsylvania
Age range: 21 Years
🧪 Interventions in This Study
- cognitive behavioral therapy (BEHAVIORAL)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- UPMC Hillman Cancer Centers — Pittsburgh, Pennsylvania
📞 Contact the Study Coordinator
Phone: (412) 692-2041
Email: steejl@upmc.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Cognitive Behavioral Therapy
Explore by condition: All Cognitive Behavioral Therapy clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.